[Hodgkin's disease associated with LDH-M subunit deficiency]

N Arai1, A Hara, M Umeda

  • 1First Department of Internal Medicine, Toho University School of Medicine, Tokyo.

Insights

This study reports the first case in Japan of Hodgkin's disease complicated by lactate dehydrogenase M (LDH-M) subunit deficiency. The patient achieved complete remission after C-MOPP therapy.

Area of Science:

  • Biochemistry
  • Oncology
  • Genetics

Background:

  • Lactate dehydrogenase M (LDH-M) subunit deficiency is a rare genetic disorder.
  • Hodgkin's disease is a cancer of the lymphatic system.

Observation:

  • A 60-year-old man presented with cervical swelling and was diagnosed with stage IA Hodgkin's disease.
  • Laboratory tests revealed homogeneous type 1 lactate dehydrogenase (LDH-H4) in serum and erythrocytes, indicating LDH-M subunit deficiency.
  • The patient did not exhibit typical symptoms like muscle rigidity or myoglobinuria.

Findings:

  • The patient received C-MOPP chemotherapy and irradiation, achieving complete remission.
  • This case represents the first reported instance of LDH-M subunit deficiency co-occurring with Hodgkin's disease in Japan.
  • Only five families with LDH-M subunit deficiency have been previously reported in Japan.

Implications:

  • This case expands the known clinical spectrum of LDH-M subunit deficiency.
  • It highlights the importance of considering rare genetic conditions in cancer patients.
  • Further research may elucidate potential links between LDH-M deficiency and cancer susceptibility or progression.